276 related articles for article (PubMed ID: 27226117)
1. Topoisomerase IIα poisoning and DNA double-strand breaking by chiral ruthenium(ii) complexes containing 2-furanyl-imidazo[4,5-f][1,10]phenanthroline derivatives.
Qian C; Wu J; Ji L; Chao H
Dalton Trans; 2016 Jun; 45(26):10546-55. PubMed ID: 27226117
[TBL] [Abstract][Full Text] [Related]
2. Dual topoisomerase I and II poisoning by chiral Ru(II) complexes containing 2-thiophenylimidazo[4,5-f][1,10]phenanthroline derivatives.
Wang YC; Qian C; Peng ZL; Hou XJ; Wang LL; Chao H; Ji LN
J Inorg Biochem; 2014 Jan; 130():15-27. PubMed ID: 24145066
[TBL] [Abstract][Full Text] [Related]
3. Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II.
Kou JF; Qian C; Wang JQ; Chen X; Wang LL; Chao H; Ji LN
J Biol Inorg Chem; 2012 Jan; 17(1):81-96. PubMed ID: 21858685
[TBL] [Abstract][Full Text] [Related]
4. Dual inhibition of topoisomerases I and IIα by ruthenium(II) complexes containing asymmetric tridentate ligands.
Du K; Liang J; Wang Y; Kou J; Qian C; Ji L; Chao H
Dalton Trans; 2014 Dec; 43(46):17303-16. PubMed ID: 25315107
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic antitumor activity of Ru(ii) complexes of imidazo-phenanthroline conjugated hydroxybenzoic acid as tumor targeting photosensitizers.
Liu ZY; Zhang J; Sun YM; Zhu CF; Lu YN; Wu JZ; Li J; Liu HY; Ye Y
J Mater Chem B; 2020 Jan; 8(3):438-446. PubMed ID: 31833531
[TBL] [Abstract][Full Text] [Related]
6. Determination of in vitro absorption in Caco-2 monolayers of anticancer Ru(II)-based complexes acting as dual human topoisomerase and PARP inhibitors.
de Camargo MS; De Grandis RA; da Silva MM; da Silva PB; Santoni MM; Eismann CE; Menegário AA; Cominetti MR; Zanelli CF; Pavan FR; Batista AA
Biometals; 2019 Feb; 32(1):89-100. PubMed ID: 30506342
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes.
Putta VR; Chintakuntla N; Mallepally RR; Avudoddi S; K N; Nancherla D; V V N Y; R S P; Surya SS; Sirasani S
J Fluoresc; 2016 Jan; 26(1):225-40. PubMed ID: 26555289
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization; DNA binding and antitumor activity of ruthenium(II) polypyridyl complexes.
Srishailam A; Gabra NM; Kumar YP; Reddy KL; Devi CS; Anil Kumar D; Singh SS; Satyanarayana S
J Photochem Photobiol B; 2014 Dec; 141():47-58. PubMed ID: 25318017
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of topoisomerase IIα and induction of DNA damage in cholangiocarcinoma cells by altholactone and its halogenated benzoate derivatives.
Kitdumrongthum S; Reabroi S; Suksen K; Tuchinda P; Munyoo B; Mahalapbutr P; Rungrotmongkol T; Ounjai P; Chairoungdua A
Biomed Pharmacother; 2020 Jul; 127():110149. PubMed ID: 32344256
[TBL] [Abstract][Full Text] [Related]
10. Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
J Inorg Biochem; 2020 Jul; 208():111104. PubMed ID: 32485635
[TBL] [Abstract][Full Text] [Related]
11. DNA binding, photocleavage, antimicrobial and cytotoxic properties of Ru(II) polypyridyl complexes containing BOPIP ligand, (BOPIP = {2-(4-(benzyloxy) phenyl)-1H-imidazo [4,5-f] [1,2]phenanthroline}).
Gopu S; Ravi Kumar V; Laxma Reddy K; Venkat Reddy P; Sirasani S
Nucleosides Nucleotides Nucleic Acids; 2019; 38(5):349-373. PubMed ID: 30890029
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structural characterization, in vitro DNA binding, and antitumor activity properties of Ru(II) compounds containing 2(2,6-dimethoxypyridine-3-yl)-1H-imidazo(4,5-f)[1, 10]phenanthroline.
Chintakuntla N; Putta VR; Mallepally RR; K N; Vuradi RK; Kotha LR; Singh SS; Sirasani S
Nucleosides Nucleotides Nucleic Acids; 2020; 39(5):760-791. PubMed ID: 31983278
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, molecular docking, RNA-sequence and anticancer efficacy evaluation in vitro of ruthenium(II) complexes on B16 cells.
Huang C; Zhang H; Yang Y; Liu H; Chen J; Wang Y; Liang L; Hu H; Liu Y
J Inorg Biochem; 2023 Oct; 247():112329. PubMed ID: 37478780
[TBL] [Abstract][Full Text] [Related]
14. Chiral ruthenium(II) complexes with phenolic hydroxyl groups as dual poisons of topoisomerases I and IIα.
Zhang P; Wang J; Huang H; Qiao L; Ji L; Chao H
Dalton Trans; 2013 Jun; 42(24):8907-17. PubMed ID: 23661230
[TBL] [Abstract][Full Text] [Related]
15. Targeting topoisomerase II with the chiral DNA-intercalating ruthenium(II) polypyridyl complexes.
Gao F; Chao H; Wang JQ; Yuan YX; Sun B; Wei YF; Peng B; Ji LN
J Biol Inorg Chem; 2007 Sep; 12(7):1015-27. PubMed ID: 17659367
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, spectral studies, DNA binding, photocleavage, antimicrobial and anticancer activities of isoindol Ru(II) polypyridyl complexes.
Ravi C; Vuradi RK; Avudoddi S; Yata PK; Putta VR; Srinivas G; Merugu R; Satyanarayana S
Nucleosides Nucleotides Nucleic Acids; 2019; 38(10):788-806. PubMed ID: 31081456
[TBL] [Abstract][Full Text] [Related]
17. Ruthenium(II) polypyridyl complexes with 1,8-naphthalimide group as DNA binder, photonuclease, and dual inhibitors of topoisomerases I and IIα.
Sun Y; Li J; Zhao H; Tan L
J Inorg Biochem; 2016 Oct; 163():88-94. PubMed ID: 27470011
[TBL] [Abstract][Full Text] [Related]
18. Enantiomeric selectivity of ruthenium (II) chiral complexes with antitumor activity, in vitro and in vivo.
Zhang W; Sun Y; Wang J; Ding X; Yang E; Martin LL; Sun D
J Inorg Biochem; 2021 Mar; 216():111339. PubMed ID: 33388703
[TBL] [Abstract][Full Text] [Related]
19. Spectral characteristics, DNA-binding and cytotoxicity of two functional Ru(II) mixed-ligand complexes.
Tan L; Shen J; Liu J; Zeng L; Jin L; Weng C
Dalton Trans; 2012 Apr; 41(15):4575-87. PubMed ID: 22358386
[TBL] [Abstract][Full Text] [Related]
20. Introducing the 4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates.
Riedl CA; Flocke LS; Hejl M; Roller A; Klose MH; Jakupec MA; Kandioller W; Keppler BK
Inorg Chem; 2017 Jan; 56(1):528-541. PubMed ID: 27996251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
